Literature DB >> 16712953

Illicit drug use and anxiety disorders: findings from two community surveys.

Jitender Sareen1, Mariette Chartier, Martin P Paulus, Murray B Stein.   

Abstract

The focus of this investigation was the relationship between anxiety disorders and lifetime use of amphetamines, cocaine, hallucinogens and heroin in two contemporaneous samples. Data from two independent community surveys conducted in the US (N=5877) and Ontario (N=8116) were used to assess whether a lifetime anxiety disorder diagnosis (social phobia, panic disorder, agoraphobia, specific phobia, and generalized anxiety disorder) was significantly associated with lifetime use of amphetamines, hallucinogens, cocaine, and heroin. Posttraumatic stress disorder was assessed only in the US survey. After controlling for sociodemographics, a significant association between any anxiety disorder diagnosis and lifetime stimulant use, cocaine use, and hallucinogen use was found in both surveys (OR approximately 1.5-3.0). Any anxiety disorder diagnosis was significantly associated with lifetime heroin use in the US survey (OR approximately 3.0). Clinicians and researchers need to be aware of the relationship between anxiety disorders and illicit drug use.

Entities:  

Mesh:

Year:  2006        PMID: 16712953     DOI: 10.1016/j.psychres.2006.01.009

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  20 in total

1.  Negative affect heightens opiate withdrawal-induced hyperalgesia in heroin dependent individuals.

Authors:  Luis M Carcoba; Arturo E Contreras; Antonio Cepeda-Benito; Mary W Meagher
Journal:  J Addict Dis       Date:  2011 Jul-Sep

2.  Management of treatment-resistant panic disorder.

Authors:  Richard L Holt; R Bruce Lydiard
Journal:  Psychiatry (Edgmont)       Date:  2007-10

3.  Pathways Between Concealable Stigmatized Identities and Substance Misuse.

Authors:  Amelia E Talley; Andrew K Littlefield
Journal:  Soc Personal Psychol Compass       Date:  2014-10

4.  Structural models of the comorbidity of internalizing disorders and substance use disorders in a longitudinal birth cohort.

Authors:  David M Fergusson; Joseph M Boden; L John Horwood
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-07-09       Impact factor: 4.328

Review 5.  Predicting treatment outcome in stimulant dependence.

Authors:  Martina Reske; Martin P Paulus
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 6.  Temporal relations between sleep problems and both traumatic event exposure and PTSD: a critical review of the empirical literature.

Authors:  Kimberly A Babson; Matthew T Feldner
Journal:  J Anxiety Disord       Date:  2010-01

Review 7.  Extinction circuits for fear and addiction overlap in prefrontal cortex.

Authors:  Jamie Peters; Peter W Kalivas; Gregory J Quirk
Journal:  Learn Mem       Date:  2009-04-20       Impact factor: 2.460

8.  Excitatory drive onto dopaminergic neurons in the rostral linear nucleus is enhanced by norepinephrine in an α1 adrenergic receptor-dependent manner.

Authors:  Megan A Williams; Chia Li; Thomas L Kash; Robert T Matthews; Danny G Winder
Journal:  Neuropharmacology       Date:  2014-07-10       Impact factor: 5.250

9.  A longitudinal investigation of powder cocaine use among club-drug using gay and bisexual men.

Authors:  Joseph J Palamar; Preetika P Mukherjee; Perry N Halkitis
Journal:  J Stud Alcohol Drugs       Date:  2008-11       Impact factor: 2.582

10.  Does Posttraumatic Stress Disorder (PTSD) Affect Post-Treatment Methamphetamine Use?

Authors:  Suzette Glasner-Edwards; Larissa J Mooney; Alfonso Ang; Maureen Hillhouse; Richard Rawson
Journal:  J Dual Diagn       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.